Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUC-MSCs for Refractory Diabetic Peripheral Neuropathy
NCT05507697Phase 2Unknown
- Sponsor
- Wuhan Central Hospital
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in diabetic peripheral neuropathy (DPN), sponsored by Wuhan Central Hospital. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT05507697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507697.